Design and regioselective synthesis of a new generation of targeted chemotherapeutics. Part 1: EC145, a folic acid conjugate of desacetylvinblastine monohydrazide
Graphical abstract
Section snippets
Acknowledgment
We thank Indiana 21st Century Grant (#511040805) for financial support.
References and notes (15)
- Yang, J.; Chen, H.; Cheng, J.-X.; Vlahov, I. R.; Low, P. S. Proc. Natl. Acad. Sci. U.S.A., in...
- et al.
Bioconjugate Chem.
(1991) - Unpublished...
- et al.
J. Med. Chem.
(1978) Annu. Rev. Nutr.
(1996)- et al.
Cancer Res.
(1991)et al.Cancer Res.
(1992)et al.Am. J. Pathol.
(1993)et al.Cancer
(1994)et al.Cancer Epidemiol. Biomarkers Prevent.
(1999)et al.J. Thoracic Cardiovasc. Surgery
(2001)
There are more references available in the full text version of this article.
Cited by (121)
Synthesis and biological evaluation of folic acid-rotenol conjugate as a potent targeted anticancer prodrug
2024, European Journal of PharmacologyAn overview of nanoparticles in drug delivery: Properties and applications
2023, South African Journal of Chemical EngineeringFolate Receptor as a Biomarker and Therapeutic Target in Solid Tumors
2023, Current Problems in CancerTargeted delivery of mPGES-1 inhibitors to macrophages via the folate receptor-β for inflammatory pain
2021, Bioorganic and Medicinal Chemistry LettersDesign and Applications of Bifunctional Small Molecules in Biology
2021, Biochimica et Biophysica Acta - Proteins and Proteomics
Copyright © 2006 Elsevier Ltd. All rights reserved.